Hexagon Bio website screenshot

Hexagon Bio

Hexagon Bio is a Menlo Park, California biotechnology company developing novel payloads for antibody-drug conjugates (ADCs) in oncology. The company designs next-generation ADC payloads intended to overcome resistance to current payloads and to expand the range of cancer indications ADCs can treat. Backed by SoftBank Vision Fund, Hexagon Bio operates a therapeutics pipeline and research platform rather than a public developer program: it publishes no API, SDK, or developer documentation surface. This profile was surfaced as a portfolio-company lead and enriched from Hexagon Bio's own public website (company, pipeline, science/platform, and news pages).

Hexagon Bio is profiled on the APIs.io network. Tagged areas include Company, Health Tech, Biotechnology, Oncology, and Antibody-Drug Conjugates.

Hexagon Bio’s developer surface includes engineering blog and 2 more developer resources.

7.2/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyHealth TechBiotechnologyOncologyAntibody-Drug ConjugatesDrug DiscoveryTherapeutics

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 7.2/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/hexagon-bio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Resources

Access & Security 1

Authentication, authorization, and security posture

Company 2

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: hexagon-bio
name: Hexagon Bio
description: 'Hexagon Bio is a Menlo Park, California biotechnology company developing novel payloads for antibody-drug conjugates
  (ADCs) in oncology. The company designs next-generation ADC payloads intended to overcome resistance to current payloads
  and to expand the range of cancer indications ADCs can treat. Backed by SoftBank Vision Fund, Hexagon Bio operates a therapeutics
  pipeline and research platform rather than a public developer program: it publishes no API, SDK, or developer documentation
  surface. This profile was surfaced as a portfolio-company lead and enriched from Hexagon Bio''s own public website (company,
  pipeline, science/platform, and news pages).'
url: https://raw.githubusercontent.com/api-evangelist/hexagon-bio/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://www.hexagonbio.com/favicon.ico
x-type: company
x-source: vc-portfolio
x-backed-by:
- softbank-vision-fund
x-tier: stub
x-tier-reason: portfolio-lead
x-website: https://www.hexagonbio.com
x-no-developer-surface: true
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Health Tech
- Biotechnology
- Oncology
- Antibody-Drug Conjugates
- Drug Discovery
- Therapeutics
apis: []
common:
- type: DomainSecurity
  url: security/hexagon-bio-domain-security.yml
- type: Website
  url: https://www.hexagonbio.com
- type: Blog
  url: https://www.hexagonbio.com/news/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence